<- Go home

Professional

[ANALYST] Redeye

Added to YB: 2024-10-29

Pitch date: 2024-10-24

NEOLA.ST [bullish]

Neola Medical AB (publ)

-53.51%

current return

Author Info

We perform researched powered investment banking with a belief that Scandinavia will be a hotspot for the major future innovations within tech and lifescience. Visit their website.

Company Info

Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies.

Market Cap

SEK 171.2M

Pitch Price

SEK 2.42

Price Target

5.80 (+416%)

Dividend

N/A

EV/EBITDA

-16.10

P/E

-16.23

EV/Sales

12.80

Sector

Health Care Equipment and Supplies

Category

growth

Show full summary:
Neola Medical: Meeting an unmet need in neonatal care

NEOLA.ST: Non-invasive neonatal lung monitoring device launching in US 2026e, EU/ANZ 2027e. Addressable market SEK92.6bn by 2032e. Razor-blade model with device (USD70-100k) and daily probes (USD400-500). SEK385m sales, 36% EBIT margin projected for 2032e. Key catalysts: clinical data, FDA/CE approvals.

Read full article (34 min)